Figure 3. High SEMA4C expression correlates with poor survival outcomes in CRC patients. (A, B) Kaplan-Meier survival curves show OS and PFS of high- and low-SEMA4C expressing CRC patients from the TCGA database. (C, D) Kaplan-Meier survival curves show the OS of high- and low-SEMA4C expressing CRC patients belonging to the metastatic and non-metastatic subgroups. (E, F) Kaplan-Meier survival curves show OS and TFS of high- and low-SEMA4C expressing CRC patients from the TMA-colon cancer cohort.